Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: Phase I studies (vol 24, pg 81, 1997)

被引:0
|
作者
Rosenthal
Carbone, DP
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:499 / 499
页数:1
相关论文
共 14 条
  • [11] Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas
    Sun, Weijing
    Metz, James M.
    Gallagher, Maryann
    O'Dwyer, Peter J.
    Giantonio, Bruce
    Whittington, Richard
    Haller, Daniel G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 621 - 627
  • [12] Phase I trial of combined-modality therapy for localized esophageal cancer: Escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy
    Brenner, B
    Ilson, DH
    Minsky, BD
    Bains, MS
    Tong, W
    Gonen, M
    Kelsen, DP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 45 - 52
  • [13] Long-term Follow-up of a Prospective Phase I-II Study of Concurrent Paclitaxel and Radiation Therapy With Hormonal Ablation in Locally Advanced Prostate Cancer
    Sanfilippo, N. J.
    Taneja, S. S.
    Chachoua, A.
    Lepor, H.
    Formenti, S. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S92 - S92
  • [14] Phase I Pharmacokinetic and Pharmacodynamic Study of Weekly 1-Hour and 24-Hour Infusion BMS-214662, a Farnesyltransferase Inhibitor, in Patients With Advanced Solid Tumors (vol 23, pg 2521, 2005)
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (36) : 5350 - 5350